Pantoprazol Sun (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Sun, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazol Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Sun is a proton pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Pantoprazol Sun may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent bowel changes.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Liver enzyme elevation: abnormal liver function tests. - Fracture risk: potential reduction in bone mineral density with long‑term use.

When prescribing Pantoprazol Sun, consider the following safety measures: - Renal impairment: adjust monitoring if kidney function is reduced. - Hepatic impairment: use with caution in patients with liver disease. - Long‑term therapy: evaluate need periodically to avoid unnecessary exposure. - Drug interactions: review concomitant medications for potential PK/PD effects. - Pregnancy and lactation: weigh benefits against potential risks. - Store at ambient temperature: keep below 25 °C, protect from moisture and keep in original packaging.

Pantoprazol Sun can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir): reduced absorption and efficacy. - Certain antifungal agents (e.g., ketoconazole, itraconazole): markedly decreased bioavailability.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of anticoagulant effect, monitor INR. - Clopidogrel: reduced conversion to active metabolite, assess platelet function. - Methotrexate (high dose): increased serum levels, monitor for toxicity. - Digoxin: modest increase in serum concentration, observe for signs of toxicity.